U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523880) titled 'Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD' on April 06.
Brief Summary: Patients with coronary heart disease who take dual antiplatelet therapy face two serious risks: thrombosis and major bleeding. This study aims to develop better ways to predict these risks and guide personalized treatment.
The investigators will use a large, long-term follow-up study of Chinese patients with coronary heart disease. This research plans to discover new biomarkers related to clot and bleeding risk. The study will combine information from proteins, metabolites, sugars attached to proteins, genes, and medical ima...